Patent Oppositions in cell cultures industry

Explore the competitive field of cell cultures where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in cell cultures technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Last updated on: Oct 29, 2026
CompanyTotal Oppositions
STRAWMAN69
JAMES POOLE28
HOFFMANN EITLE26
BOEHRINGER INGELHEIM20
BAXALTA16
KYMAB16
REPLIGEN15
PATENT BOUTIQUE12
BOULT WADE TENNANT12
STORZ12

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the cell cultures industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the cell cultures industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Oct 29, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Mucosal-Associated Invariant T (Mait) Cells Expressing Chimeric Antigen ReceptorsUNIVERSIT PARIS CITOct 28, 2026GOODWIN PROCTER UK
Use Of Perfusion Seed Cultures To Improve Biopharmaceutical Fed-Batch Production Capacity And Product QualityBIOGEN MAOct 21, 2026MAIWALD PATENTANWALTS
Use Of Perfusion Seed Cultures To Improve Biopharmaceutical Fed-Batch Production Capacity And Product QualityBIOGEN MAOct 20, 2026STRAWMAN
Methods And Compositions For Transducing And Expanding Lymphocytes And Regulating The Activity ThereofEXUMA BIOTECHOct 7, 2026PATENT BOUTIQUE
Cytotoxicity-Inducing Therapeutic AgentCHUGAI SEIYAKU KABUSHIKI KAISHASep 29, 2026STRAWMAN
Method And Compositions For Cellular ImmunotherapySEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RESEARCH INSTITUTEAug 26, 2026EIP
Methods For Activating, Modifying And Expanding Gamma Delta T Cells For The Treatment Of Cancer And Related MalignanciesIMMATICSJul 13, 2026MILTENYI BIOTEC
Method For Producing Cd8Alpha+Beta+Cytotoxic T CellsKYOTO UNIVERSITYJul 6, 2026MARGARET DIXON
A Method For High Level And Stable Gene Transfer In LymphocytesJULIUS MAXIMILIANS UNIVERSITT WRZBURGJul 3, 2026MAX DELBRUCK CENTRUM FUR MOLEKULARE MEDIZIN IN DER HELMHOLTZ GEMEINSCHAFT
Antibody Producing Non-Human MammalsMERUSJun 3, 2026KYMAB

To stay ahead in the competitive cell cultures industry, companies are constantly innovating. Here are the top patents facing oppositions in the cell cultures industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Oct 29, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS10
May 10, 2017Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of TranscriptionTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA7
Aug 7, 2019Methods To Mobilize Progenitor/Stem CellsGENZYME7
Nov 8, 2017Improved Cell Cultivation ProcessNOVARTIS7
Feb 24, 2021Process For Cultivation Of Cho CellsNOVARTIS6
Apr 19, 2017Oligopeptide-Free Cell Culture MediaBAXALTA INCORPORATED6
Apr 22, 2020Oligopeptide-Free Cell Culture MediaBAXALTA INCORPORATED6
Jan 21, 2026Use Of Perfusion Seed Cultures To Improve Biopharmaceutical Fed-Batch Production Capacity And Product QualityBIOGEN MA5
Sep 12, 2018Cytotoxicity-Inducing Therapeutic AgentCHUGAI SEIYAKU KABUSHIKI KAISHA5
Apr 12, 2017Cell Culture Method Using Amino Acid-Enriched MediumCHUGAI SEIYAKU KABUSHIKI KAISHA5